Charles River Laboratories International, Inc.
CRL
$138.79
-$2.57-1.82%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.47M | -214.50M | 69.66M | 94.08M | 67.33M |
| Total Depreciation and Amortization | 84.86M | 92.70M | 88.20M | 86.08M | 85.36M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.08M | 323.55M | 22.45M | 24.70M | 25.29M |
| Change in Net Operating Assets | 1.29M | -42.40M | 71.49M | -11.33M | -48.09M |
| Cash from Operations | 171.70M | 159.36M | 251.79M | 193.54M | 129.89M |
| Capital Expenditure | -59.32M | -75.62M | -38.72M | -39.49M | -79.14M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | -5.48M | -- |
| Divestitures | 17.44M | -- | -- | -- | -- |
| Other Investing Activities | -3.60M | -488.00K | 17.40M | -16.90M | -6.65M |
| Cash from Investing | -45.48M | -76.10M | -21.32M | -61.87M | -85.79M |
| Total Debt Issued | 416.34M | 104.80M | 235.58M | 440.32M | 300.88M |
| Total Debt Repaid | -149.39M | -176.78M | -329.65M | -694.86M | -292.48M |
| Issuance of Common Stock | -- | 768.00K | 779.00K | 826.00K | 21.51M |
| Repurchase of Common Stock | -353.13M | -124.00K | -100.79M | -8.91M | -9.35M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.14M | -4.54M | -13.47M | -23.23M | -2.21M |
| Cash from Financing | -105.33M | -75.88M | -207.54M | -285.86M | 18.35M |
| Foreign Exchange rate Adjustments | 5.27M | -13.45M | 7.70M | -3.34M | -8.39M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.16M | -6.07M | 30.64M | -157.53M | 54.06M |